Watch These Marijuana Stocks Hit The Ground Running On Wednesday (2/6/19)

CORAL GABLES, FL / ACCESSWIRE / February 6, 2019 / Marijuana stocks have had quite a solid weeks during the beginning of February. Companies in the sector have enjoyed significant movement due to major legislative changes in domestic markets, as well as on a global scale. Following the passing of the U.S. Farm Bill, which will allow nearly $900 million to go to the agricultural industry, as well as legalize the production of hemp, investor attention for the cannabis sector has been at an all-time high. American Premium Water Corporation (OTC:HIPH), iAnthus Capital Holdings Inc (ITHUF) (IAN.CN), PotNetwork Holdings Inc (OTC PINK: POTN), and Cara Therapeutics Inc (CARA) are 4 pot stocks that are bringing the heat on Wednesday.

American Premium Water Corporation (OTC:HIPH) is a company you may not have heard of but could benefit from taking a look at. The Company is a luxury consumer products corporation invested in discovering different use cases for the molecular potential of hydrogen, as well as nanotechnologies, in congruence with cannabidiol (CBD) to optimize product offerings to treat health disorders and enhance the quality of life for consumers.

American Premium Water Corporation (OTC:HIPH) announced prior to the events of this year's Super Bowl LIII in Atlanta, Georgia, that the Company would once again have a presence in activities and networking events leading up to the big game. Per the announcement, the Company's Gents and LALPINA brands were featured in a number of events with the Willis and Walker brand, a luxury menswear brand founded by Kevin Willis, an NBA All-Star.

Ryan Fishoff, Chief Executive Officer and Interim Chairman of American Premium Water Corporation (OTC:HIPH), commented at the time, "I am excited that the Company will once again be participating in Super Bowl festivities. Last year's events were tremendous exposure for the Company and its brands. With all the strides we've made over the past year, I am excited to be there again and continue progressing forward. Its also nice that the Super Bowl is being held in a much warmer climate (Atlanta) than Minnesota, I won't need four layers to go outside, which will allow me to pack more Gents hats and LALPINA CBD water in my carry-on!"

For More Information On American Premium Water Corporation, Click Here

iAnthus Capital Holdings Inc (ITHUF) (IAN) today announced that, in partnership with MPX Bioceutical Corporation, the two companies have closed their previously announced plan of arrangement, pursuant to which iAnthus will acquire all of the issued and outstanding common shares of MPX.

Hadley Ford, CEO of iAnthus, commented, "2019 will be a transformative year for iAnthus, with the closing of our business combination with MPX being a crucial step forward. As the U.S. cannabis market continues to expand with increasing consumer and regulatory acceptance, iAnthus will continue to execute and provide the quality products and brands that our customers demand."

For More Information On iAnthus Capital Holdings Inc, Click Here

PotNetwork Holdings Inc (POTN) announced earlier this week that one of its wholly-owned subsidiaries, Diamond CBD, will begin installing they new Brain Chill Slushy Machines in stores located throughout South Florida. These slushy machines serve frozen slush drinks, available in Wild Cherry, Cola, Grape, Blue Raspberry, Lemonade And Iced Coffee flavors, infused with high-quality CBD extract. Each 12oz cup of the Brain Chill Slushy contains 100mg of full spectrum CBD.

Following the announcement, Kevin Hagen, CEO of PotNetwork Holdings, said, "I'm ecstatic about these slushy machines! They're great conversation builders, instrumental in building a positive rapport with customers about CBD, and why CBD is so beneficial. We expect these machines to be a huge hit for stores all across South Florida and we also wish to expand to other cities and states in the near future."

For More Information On PotNetwork Holdings Inc, Click Here

Cara Therapeutics Inc (CARA) saw its shares enjoy a 2.45% boost in mid-afternoon trading on Wednesday, with shares trading at $15.87 per share. In early January, the Company announced the completion of enrollment in the KALM-1 Phase 3 trial of KORSUVAâ„¢ (CR845/difelikefalin) Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). At the time of the announcement, more than 350 hemodialysis patients with CKD-aP had been randomized across approximately 60 clinical sites in the United States.